{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:56:35Z","timestamp":1792432595442,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273154"],"award-info":[{"award-number":["82273154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["202201010511"],"award-info":[{"award-number":["202201010511"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["21620106"],"award-info":[{"award-number":["21620106"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["21622321"],"award-info":[{"award-number":["21622321"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012541"],"award-info":[{"award-number":["2023A1515012541"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cbi.2023.110816","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T17:59:29Z","timestamp":1700675969000},"page":"110816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting \u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"387","author":[{"given":"Wenna","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuling","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengdong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2023.110816_bib1","first-page":"1198","article-title":"A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research","volume":"15","author":"McGlynn","year":"2006","journal-title":"cosponsored by American Soc. Preventive Oncol."},{"key":"10.1016\/j.cbi.2023.110816_bib2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Rizvi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2023.110816_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncol."},{"key":"10.1016\/j.cbi.2023.110816_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","article-title":"Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections","volume":"258","author":"Nagino","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.cbi.2023.110816_bib5","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jamasurg.2013.5168","article-title":"A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience","volume":"149","author":"Hyder","year":"2014","journal-title":"JAMA Surgery"},{"key":"10.1016\/j.cbi.2023.110816_bib6","first-page":"557","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management, Nature reviews","volume":"17","author":"Banales","year":"2020","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2023.110816_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","article-title":"Systemic therapies for intrahepatic cholangiocarcinoma","volume":"72","author":"Kelley","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2023.110816_bib8","first-page":"783","article-title":"Phase II study of systemic gemcitabine chemotherapy for advanced unresectable hepatobiliary carcinomas","volume":"48","author":"Kubicka","year":"2001","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.cbi.2023.110816_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00228-017-2260-0","article-title":"Chemotherapy-induced neutropenia as a prognostic factor in patients with metastatic pancreatic cancer treated with gemcitabine","volume":"73","author":"Otake","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2023.110816_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bbrc.2012.03.122","article-title":"DCK is frequently inactivated in acquired gemcitabine-resistant human cancer cells","volume":"421","author":"Saiki","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2023.110816_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ygeno.2004.08.010","article-title":"Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes","volume":"84","author":"Altenberg","year":"2004","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2023.110816_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2023.110816_bib13","doi-asserted-by":"crossref","first-page":"14366","DOI":"10.1016\/S0021-9258(18)47947-1","article-title":"The L- and R-type isozymes of rat pyruvate kinase are produced from a single gene by use of different promoters","volume":"262","author":"Noguchi","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2023.110816_bib14","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1016\/S0021-9258(18)67091-7","article-title":"The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing","volume":"261","author":"Noguchi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2023.110816_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020775","article-title":"PKM2 modulation in head and neck squamous cell carcinoma","volume":"23","author":"Boschert","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2023.110816_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41419-021-03990-4","article-title":"Lactate secreted by PKM2 upregulation promotes Galectin-9-mediated immunosuppression via inhibiting NF-\u03baB pathway in HNSCC","volume":"12","author":"Chang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2023.110816_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589997","article-title":"PKM2 drives hepatocellular carcinoma progression by inducing immunosuppressive microenvironment","volume":"11","author":"Li","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2023.110816_bib18","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s11010-020-04041-w","article-title":"PKM2 promotes cell metastasis and inhibits autophagy via the JAK\/STAT3 pathway in hepatocellular carcinoma","volume":"476","author":"Yu","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2023.110816_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1158\/0008-5472.CAN-21-0403","article-title":"PKM2 is essential for bladder cancer growth and maintenance","volume":"82","author":"Xia","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2023.110816_bib20","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.7150\/ijbs.27854","article-title":"PKM2 inhibitor shikonin overcomes the cisplatin resistance in bladder cancer by inducing necroptosis","volume":"14","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2023.110816_bib21","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.7150\/thno.43839","article-title":"Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2\/HIF-1\u03b1 axis","volume":"10","author":"Hua","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2023.110816_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","article-title":"PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis","volume":"150","author":"Yang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2023.110816_bib23","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190613","article-title":"PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation","volume":"217","author":"Damasceno","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cbi.2023.110816_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.cmet.2019.10.015","article-title":"Pharmacological activation of pyruvate kinase M2 inhibits CD4(+) T cell pathogenicity and suppresses autoimmunity","volume":"31","author":"Angiari","year":"2020","journal-title":"Cell Metabol."},{"key":"10.1016\/j.cbi.2023.110816_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.canlet.2020.11.018","article-title":"Pyruvate kinase M2 (PKM2) in cancer and cancer therapeutics","volume":"503","author":"Zhu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2023.110816_bib26","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.7150\/ijbs.62947","article-title":"Inhibition of PKM2 enhances sensitivity of olaparib to ovarian cancer cells and induces DNA damage","volume":"18","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2023.110816_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13046-020-01605-y","article-title":"PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma","volume":"39","author":"Martin","year":"2020","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.cbi.2023.110816_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2017.06.064","article-title":"Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase","volume":"138","author":"Ning","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2023.110816_bib29","first-page":"305","article-title":"Gamma-H2AX - a novel biomarker for DNA double-strand breaks, in vivo (Athens, Greece)","volume":"22","author":"Kuo","year":"2008"},{"key":"10.1016\/j.cbi.2023.110816_bib30","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1136\/gutjnl-2021-325150","article-title":"FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2","volume":"71","author":"Rao","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.cbi.2023.110816_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-021-02235-8","article-title":"Macrophages-aPKC(\u0269)-CCL5 feedback loop modulates the progression and chemoresistance in cholangiocarcinoma","volume":"41","author":"Yang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.cbi.2023.110816_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119205","article-title":"Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt\/\u03b2-catenin pathway","volume":"287","author":"Hua","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2023.110816_bib33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-020-01237-y","article-title":"LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt\/\u03b2-catenin and autophagy pathway through modulating the miR-619-5p\/Pygo2 and miR-619-5p\/ATG14 axes","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110816_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103488","article-title":"MiR-624-5p enhances NLRP3 augmented gemcitabine resistance via EMT\/IL-1\u03b2\/Wnt\/\u03b2-catenin signaling pathway in ovarian cancer","volume":"150","author":"Alrashed","year":"2022","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.cbi.2023.110816_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-015-0490-2","article-title":"PKM2 promotes tumor angiogenesis by regulating HIF-1\u03b1 through NF-\u03baB activation","volume":"15","author":"Azoitei","year":"2016","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110816_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature10598","article-title":"Nuclear PKM2 regulates \u03b2-catenin transactivation upon EGFR activation","volume":"480","author":"Yang","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2023.110816_bib37","doi-asserted-by":"crossref","first-page":"48155","DOI":"10.18632\/oncotarget.10179","article-title":"AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2023.110816_bib38","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.7150\/thno.51797","article-title":"Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.cbi.2023.110816_bib39","doi-asserted-by":"crossref","first-page":"13906","DOI":"10.1080\/21655979.2022.2086378","article-title":"Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway","volume":"13","author":"Dai","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.cbi.2023.110816_bib40","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/s41422-018-0086-7","article-title":"Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair","volume":"28","author":"Sizemore","year":"2018","journal-title":"Cell Res."},{"key":"10.1016\/j.cbi.2023.110816_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-022-01587-9","article-title":"Hsa-miR-3178\/RhoB\/PI3K\/Akt, a novel signaling pathway regulates ABC transporters to reverse gemcitabine resistance in pancreatic cancer","volume":"21","author":"Gu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110816_bib42","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2023.110816_bib43","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12964-022-00974-5","article-title":"RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway","volume":"20","author":"Zhang","year":"2022","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.cbi.2023.110816_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-023-02671-8","article-title":"Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo\/YAP1\/c-Jun axis","volume":"42","author":"Zhou","year":"2023","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.cbi.2023.110816_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cbi.2018.05.007","article-title":"Licoricidin enhances gemcitabine-induced cytotoxicity in osteosarcoma cells by suppressing the Akt and NF-\u03baB signal pathways","volume":"290","author":"Wang","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2023.110816_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-018-0305-7","article-title":"Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting \u03b2-catenin by activating PKM2 and inactivating PTEN","volume":"9","author":"Zheng","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2023.110816_bib47","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/s41416-020-01118-7","article-title":"APC loss induces Warburg effect via increased PKM2 transcription in colorectal cancer","volume":"124","author":"Cha","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cbi.2023.110816_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/mt.2013.233","article-title":"Knockdown of \u03b2-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo, Molecular therapy","volume":"22","author":"Dudek","year":"2014","journal-title":"J. American Soc. Gene Therapy"},{"key":"10.1016\/j.cbi.2023.110816_bib49","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-021-01934-6","article-title":"Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt\/\u03b2-catenin pathway","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res. : CR"},{"key":"10.1016\/j.cbi.2023.110816_bib50","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12943-017-0583-1","article-title":"The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt\/\u03b2-catenin signaling","volume":"16","author":"Han","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cbi.2023.110816_bib51","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1242\/jcs.199893","article-title":"Nuclear \u03b1-catenin mediates the DNA damage response via \u03b2-catenin and nuclear actin","volume":"130","author":"Serebryannyy","year":"2017","journal-title":"J. Cell Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723004830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279723004830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:46:04Z","timestamp":1736361964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279723004830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":51,"alternative-id":["S0009279723004830"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110816","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PKM2 improves the gemcitabine sensitivity of intrahepatic cholangiocarcinoma cells via inhibiting \u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2023.110816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110816"}}